- Allergy and Asthma Network Mothers of Asthmatics - http://www.aanma.org -

FDA Final Rule on MDI Transition

On April 14, 2010 @ 3:33 pm In All Articles

[1]The Food and Drug Administration (FDA) has announced that seven more metered dose inhalers (MDIs) containing ozone-depleting propellants will be phased out.

Four of the medications have already been discontinued: Tilade, Intal, Azmacort and Alupent; and two of the remaining three have a small market share: Aerobid and MaxAir. Combivent is used by patients with chronic obstructive pulmonary disease (COPD) and by some patients who have both COPD and asthma.

The phase-out dates for each of these can be read here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm. [2] [^ [2]]

We expect that an Aerobid HFA replacement will be approved prior to its phase-out. We expect the same for Combivent.

Visit our website, http://www.aanma.org [3], for more news and updates from AANMA. Thank you.

Article printed from Allergy and Asthma Network Mothers of Asthmatics: http://www.aanma.org

URL to article: http://www.aanma.org/2010/04/fda-final-rule-on-mdi-transition/

URLs in this post:

[1] Image: http://www.aanma.org/wordpress/wp-content/uploads/FDA_logo.jpg

[2] http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm.: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm

[3] http://www.aanma.org: http://www.aanma.org

[4] Ask Dr. White: Is This COPD?: http://www.aanma.org/2009/02/ask-dr-white-is-this-copd/

Copyright © 2010 Allergy and Asthma Network Mothers of Asthmatics. All rights reserved. http://www.aanma.org